“Skin cancer is the most common cancer in the United States, and nonmelanoma skin cancer is the most common type of skin cancer, affecting more than 3 million Americans every year. Moreover, NMSC incidence is growing at an exponential rate. Between 1976-1984 and 2000-2010, the overall incidence of basal cell carcinoma (BCC) increased by 145 percent, and the overall incidence of squamous cell carcinoma (SCC) increased by 263 percent.”
Published online in the Journal of the American Academy of Dermatology, these evidence-based guidelines were developed by board-certified dermatologists and other experts in the field. They cover best practices for the management of NMSC, including recommendations on biopsy and pathology, treatment, metastatic disease, and patient follow-up.
According to the guidelines, surgical treatment–including excision, Mohs surgery, or curettage and electrodessication–is the most effective option for most patients with NMSC. In some cases, however, doctors may consider other treatments, such as cryotherapy, radiation or topical therapy.
Patients should receive an exam to check for new skin cancers at least once a year and take steps to prevent the development of future skin cancers, according to the guidelines. The AAD recommends that everyone, regardless if they have had a previous skin cancer or not, should protect themselves from the sun’s harmful ultraviolet rays by seeking shade, wearing protective clothing, and using a broad-spectrum, water-resistant sunscreen with an SPF of 30 or higher.
The AAD also recommends that everyone perform regular skin self-exams to detect skin cancer early, when it’s most treatable. Those who notice any new or suspicious spots on their skin, as well as anything changing, itching or bleeding, should see a board-certified dermatologist.
Hear from the AAD President-Elect, Suzanne Olbricht, MD, who will provide an overview of the new AAD NMSC guidelines at the 2018 South Beach Symposium on Thursday, March 1 at 4:00 pm.
The South Beach Symposium provides comprehensive education for healthcare professionals to stay informed on the newest therapies, technologies and practice guidelines in medical dermatology, cosmetic dermatology and aesthetic medicine.